| |
| Fundamental |
 |
China Pharma Holdings, Inc.
Consolidated Statements of Operations** |
9 Months Ending |
Year End December, 31 |
| September 30, 2007 |
2006* |
2005* |
2004* |
| |
(unaudited) |
(audited) |
(unaudited) |
(unaudited) |
| Revenues |
$24,097,521 |
$21,843,262 |
$14,075,521 |
$7,739,957 |
| Cost of revenues |
13,018,566 |
11,745,815 |
7,568,423 |
4,615,491 |
| Gross Profit |
11,078,955 |
10,097,447 |
6,507,098 |
3,124,466 |
| Selling Expenses |
896,128 |
260,128 |
145,233 |
79,905 |
| General & Administrative expense |
1,912,266 |
1,213,828 |
173,478 |
356,993 |
| Total operating expenses |
3,655,216 |
1,473,956 |
318,711 |
436,898 |
| Income from Operations |
7,423,739 |
8,623,491 |
6,188,387 |
2,687,568 |
| Non-operating income (expenses) |
1,361,203 |
-36,405 |
-178,611 |
-153,318 |
| Pretax Income |
8,784,942 |
8,587,086 |
6,009,726 |
2,534,250 |
| Income tax |
------ |
------ |
-230,824 |
-196,929 |
| Net income |
8,784,942 |
8,587,086 |
5,778,901 |
2,337,321 |
| Consolidated Balance Sheet** |
September 30 |
December 31 |
| |
2007 |
2006 |
| |
(unaudited) |
(audited) |
| Total Current Assets |
$38,179,935 |
$25,707,128 |
| Total Non-current Assets |
4,704,531 |
2,807,253 |
| Total Assets |
42,884,466 |
28,514,381 |
| Total Current Liabilities |
8,196,548 |
7,632,192 |
| Total Liabilities |
8,229,803 |
5,801,892 |
| Total Shareholders' Equity |
34,654,663 |
20,850,209 |
| Total Liabilities and Shareholders' Equity |
42,884,466 |
28,514,381 |
* Unaudited financial data provided by China Pharma. The information provided is not intended to reflect U.S. GAAP and is provided for informational purposes only. On June 16, 2005, Onny acquired Hainan Helpson Medical & Biotechnology Co., Ltd. (“Helpson”), which is the main operating unit of China Pharma. The financial statements reflected in SEC filings include accounts and operations of Helpson from the date of its acquisition on June 16, 2005. For additional information please refer to the notes accompanying the financial statement in the 10K SEC filings.
** Selected data only – Please refer to the Company’s filings with the SEC for complete data and notes thereto.
|
|
|
|
